Biotek-snakken — December 2021
-
Australia's CSL Confirms Takeover Talks With Swiss Drugmaker Vifor Pharma https://www.proinvestor.com/investornyt/748402/australias-csl-confirms-takeover-talks-with-swiss-drugmaker-vifor-pharma
-
ASH21: Precision Bio's allogeneic CAR T therapy faces durability issues https://firstwordpharma.com/story/5460395
-
Sanofi, Alnylam's fitusiran hits bleeding endpoints in haemophilia studies https://firstwordpharma.com/story/5448781
-
AstraZeneca Elated On Calquence Data,
IMGN's IMGN632 Appears To Be Promising In AML, XRTX On Watch https://www.proinvestor.com/investornyt/748420/astrazeneca-elated-on-calquence-data-imgns-imgn632-appears-to-be-promising-in-aml-xrtx-on-watch -
Roche Unveils New Automated AVENIO Edge System - Quick Facts https://www.proinvestor.com/investornyt/748425/roche-unveils-new-automated-avenio-edge-system-quick-facts
-
Regeneron : Phase 3 Results Show Dupixen Improved Skin Clearance In Children With Atopic Dermatitis https://www.proinvestor.com/investornyt/748426/regeneron-phase-3-results-show-dupixen-improved-skin-clearance-in-children-with-atopic-dermatitis
-
Oxford Biomedica Signs LSA With Arcellx, Extends Deal With Novartis - Quick Facts https://www.proinvestor.com/investornyt/748432/oxford-biomedica-signs-lsa-with-arcellx-extends-deal-with-novartis-quick-facts
-
Spændende
RNA aptamer neutraliserer at covid kan trænge ind i cellerne - https://www.pnas.org/content/118/50/e2112942118 -
Cantargia reports positive results for CAN10 antibody in preclinical systemic sclerosis
model https://www.proinvestor.com/index.php?p=debat_1&postid=99409 -
Lilly sender amerikanske biotekaktie til vejrs med stor aftale https://www.proinvestor.com/investornyt/748494/lilly-sender-amerikanske-biotekaktie-til-vejrs-med-stor-aftale
-
Xbrane initierar utveckling av två nya biosimilarkandidater och bygger en biosimilarportfölj inom onkologi som adresserar €23 miljarder i årlig försäljning på referensprodukterna
-
Roche's SARS-CoV-2 Antigen Self Test Nasal Gets Approval In Canada
https://www.proinvestor.com/investornyt/748998/roches-sars-cov-2-antigen-self-test-nasal-gets-approval-in-canada -
GN Hearing acquires New York based Lively https://www.proinvestor.com/index.php?p=debat_1&postid=99425
-
Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod...https://www.proinvestor.com/investornyt/749005/mercks-hiv-trials-put-on-clinical-hold-vifor-gets-a-suitor-veru-scores-fda-nod
-
Australia's CSL Agrees To Buy Vifor Pharma For $11.7 Bln In Cash - Quick Facts
https://www.proinvestor.com/investornyt/749001/australias-csl-agrees-to-buy-vifor-pharma-for-117-bln-in-cash-quick-facts
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind